Changes in mean GS-C over time , FDS `` responder '' status defined as either @ m/s gain in GS-C ( the minimal clinically important difference -LSB- MCID -RSB- ) or advancing by one Perry Ambulation Category ( PAC ) , and the incidence and nature of adverse events ( AEs ) .